Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
BiomX Inc. PHGE-UN
$0.45
+$0.39 (87.71%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
8881900.00000000
-
week52high
4.60
-
week52low
0.15
-
Revenue
-134000
-
P/E TTM
-2691
-
Beta
1.31009700
-
EPS
-1.31100000
-
Last Dividend
0.28500000
-
Next Earnings Date
29 мар 2023 г. в 06:00
Описание компании
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Ladenburg Thalmann | Buy | 15 апр 2021 г. | |
HC Wainwright & Co. | Buy | 07 дек 2020 г. | |
Cantor Fitzgerald | Overweight | 09 янв 2020 г. | |
Chardan Capital | Buy | Buy | 24 мая 2022 г. |
Ladenburg Thalmann | Buy | Buy | 12 мая 2022 г. |
Chardan Capital | Buy | Buy | 16 ноя 2021 г. |
Chardan Capital | Buy | Buy | 19 окт 2021 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Ugwumba Chidozie | D | 2997025 | 1501 | 04 ноя 2022 г. |
Ugwumba Chidozie | D | 2998526 | 2000 | 03 ноя 2022 г. |
Ugwumba Chidozie | D | 3000526 | 2416 | 02 ноя 2022 г. |
Ugwumba Chidozie | D | 3002942 | 1300 | 01 ноя 2022 г. |
Ugwumba Chidozie | D | 3004242 | 3300 | 31 окт 2022 г. |
Ugwumba Chidozie | D | 3007542 | 1526 | 28 окт 2022 г. |
Ugwumba Chidozie | D | 3009068 | 1505 | 27 окт 2022 г. |
Ugwumba Chidozie | D | 3010573 | 12500 | 26 окт 2022 г. |
Ugwumba Chidozie | D | 3023073 | 3072 | 25 окт 2022 г. |
Ugwumba Chidozie | D | 3026145 | 5900 | 24 окт 2022 г. |
Свежие комментарии
Свежие комментарии